UnknownNot Applicable

International Lymphatic Disease and Lymphedema Registry

United States5,000 participantsStarted 2009-03

Plain-language summary

The purpose of the International Lymphatic Disease and Lymphedema Patient Registry and Biorepository is to collect health information in order to study the disease classification, natural history, and impact of Lymphatic Disease, Lymphedema and Related Disorders and its treatments and medical outcomes.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Presence of lymphatic disease Exclusion Criteria: * None

What they're measuring

prevalence of lymphatic disease

Timeframe: 15 years

Trial details

NCT IDNCT01336790

SponsorStanford University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12

Contact for this trial

Stanley Rockson, MD

(650) 7231396

View on ClinicalTrials.gov More Lymphedema trials